A novel PIK3CA hotspot mutation in Isfahanian breast cancer patients

Cancer Invest. 2011 May;29(4):313-7. doi: 10.3109/07357907.2010.550593. Epub 2011 Feb 23.

Abstract

Somatic mutations of phosphatidylinositol 3-kinase (PI3K) catalytic subunit (PIK3CA) play an important role in tumorigenesis. Using PCR-SSCP, followed by sequencing, we examined the PIK3CA gene over the previously identified mutational hotspots in a panel of 50 breast cancer and 5 normal breast tissue, as well as 50 normal blood samples isolated from a population of Iranian patients. In the present study, the frequency of PIK3CA mutation was 14%. However, the previously identified hotspot mutations in exons 20 were completely absent in these breast cancer samples. Instead, we found a new hotspot mutation (3 of 50 samples) in exon 20.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Asian People / genetics*
  • Base Sequence
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / ethnology
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / secondary
  • Case-Control Studies
  • Chi-Square Distribution
  • Class I Phosphatidylinositol 3-Kinases
  • DNA Mutational Analysis
  • Exons
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Iran / epidemiology
  • Lymphatic Metastasis
  • Middle Aged
  • Molecular Sequence Data
  • Mutation*
  • Neoplasm Staging
  • Odds Ratio
  • Phenotype
  • Phosphatidylinositol 3-Kinases / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Single-Stranded Conformational
  • Risk Assessment
  • Risk Factors

Substances

  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human